Boston Scientific reports cyber incident disrupting operations

Boston Scientific, a medical device company, disclosed on Wednesday that it has experienced a cybersecurity incident which has disrupted its global operations. The attack affected some of the company's information systems responsible for processing and shipping customer orders. The disruption was first detected on Tuesday, prompting the company to activate its incident-response protocols.

Boston Scientific is collaborating with third-party cybersecurity experts to investigate and mitigate the threat. Consequently, the company's shares dropped approximately 5% in premarket trading. The cyberattack is anticipated to impact certain aspects of the company's business during the recovery phase. As of now, Boston Scientific has not assessed whether the incident will have a material effect on its overall business.

The company emphasizes that the impact remains undetermined. Boston Scientific's announcement comes amidst a rising trend of cyberattacks targeting the healthcare industry. Notable recent targets include medical device manufacturers Abbott Laboratories, Stryker, and Medtronic, as well as health insurer Clover Health, drugmaker Novo Nordisk, and drug-delivery equipment supplier West Pharmaceutical Services.

This report was AI-generated and subsequently reviewed by an editor. For additional details, please refer to the Terms and Conditions.